Press Releases

Date	Title	Company
13-Jul-2022	AM Best Affirms Credit Ratings of Blue Whale Re Ltd.	Businesswire
13-Jul-2022	Videojet Introduces Safer, More Sustainable Continuous Inkjet Ink with Excellent Condensation Resistance	Businesswire
13-Jul-2022	AIM-HI Accelerator Fund Announces Prestigious Beacon Award for Women Leaders in Oncology	Businesswire
13-Jul-2022	Professor Rachel West Honored with KY CHA Award in Stem Cell Technology	Businesswire
13-Jul-2022	NutriSense Raises $25 Million to Drive Continued Growth	Businesswire
13-Jul-2022	Expansion of AESARA Europe with the Appointment of Market Access Expert, Sameera Tak	Businesswire
13-Jul-2022	BeiGene Appoints Chan Lee as General Counsel	Businesswire
13-Jul-2022	Endevica Bio Doses First Patient in Phase 1 Clinical Trial of TCMCB07 for the Treatment of Cachexia	Businesswire
13-Jul-2022	Anumana Collaborates with Leading Global Health Care Company to Detect Heart Disease Using Artificial Intelligence	Businesswire
13-Jul-2022	FSD Pharma Subsidiary Lucid Psycheceuticals Files for Patent On Novel Formulations of Palmitoylethanolamide, Presents Preclinical Toxicology Results at an International Symposium	Businesswire
13-Jul-2022	Model N Announces Date of Third Quarter Fiscal Year 2022 Financial Results	Businesswire
13-Jul-2022	Edge Market Research from Stratus and Espalier Reveals Top Use Cases and Industries Driving Up to 46% Growth Through 2026	Businesswire
13-Jul-2022	BedRock Systems and U.S. Army Combat Capabilities Development Command Aviation & Missile Center to Demonstrate Trusted Computing Base Integration Framework	Businesswire
13-Jul-2022	InVivo Therapeutics Announces Appointment of Heather M. Hamel as Chief Legal Officer and General Counsel	Businesswire
13-Jul-2022	DNAnexus and Twist Bioscience Collaborate to Provide Data Analysis Software for NGS Workflow	Businesswire
13-Jul-2022	Flywheel Launches New Products to Accelerate Clinical Research and Clinical Trials Data Management	Businesswire
13-Jul-2022	Bio-Thera Solutions Announces First Patient Dosed in Phase 1 Study for BAT8006, an Antibody Drug Conjugate Targeting Folate Receptor α for the Treatment of Advanced Solid Tumors	Businesswire
13-Jul-2022	Xilis Announces Series A Extension, Bringing Total Round to Over US$89 Million	Businesswire
13-Jul-2022	Enveric Biosciences Advances Drug Development for Mental Health Indications and Intellectual Property Portfolio	Businesswire
13-Jul-2022	Marinus Pharmaceuticals to Provide Business Update and Report Second Quarter 2022 Financial Results on August 11, 2022	Businesswire